These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1412790)

  • 1. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
    Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P; Chen H; Luo H; Xu D; Shan X; Wu J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract]   [Full Text] [Related]  

  • 7. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
    Ferraresso M; Wang ME; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H; Wu J; Luo H; Daloze P
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
    Stepkowski SM; Chen H; Daloze P; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):507-8. PubMed ID: 1990602
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
    Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
    Chen H; Luo H; Daloze P; Xu D; Shan X; St-Louis G; Wu J
    Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
    Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
    Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2239-40. PubMed ID: 1714651
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G; Hancock WW; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):427-9. PubMed ID: 7879048
    [No Abstract]   [Full Text] [Related]  

  • 17. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.